Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
MYRIAD GENETICS, INC.
AI Executive Summary
AI-powered analysis of 8-K filing content
Myriad Genetics stockholders approved an amendment to the 2012 Employee Stock Purchase Plan on June 4, 2026, authorizing an additional 4,000,000 shares for issuance. This action reflects the company's commitment to employee retention and engagement through enhanced equity compensation.
Key Takeaways
4,000,000 additional shares authorized under the 2012 Employee Stock Purchase Plan
Amendment approved at the 2026 Annual Meeting of Stockholders on June 4, 2026
2 more takeaways